Free and open to the public. Parking is $10 at the UCI Student Center. RSVP required. Please click on the Buy Tickets button below.
Can we detect and treat Alzheimer's disease a decade before dementia? (And why we must!)
Dr. Sperling is a clinical neurologist, a neuroimaging researcher, and a leading force in the movement toward earlier diagnosis and treatment of Alzheimer's disease. She directs the Center for Alzheimer Research and Treatment at Brigham and Women's Hospital, the Harvard Aging Brain Study at Massachusetts General Hospital, and is a Professor of Neurology at Harvard Medical School in Boston. Her pioneering work in multi-modality brain imaging has helped advance the field's understanding of memory changes in aging and early Alzheimer's disease. She chaired the National Institute on Aging/Alzheimer's Association Workgroup, proposing a research framework to define the "preclinical stages" of Alzheimer's disease and to facilitate early intervention trials. She is actively working on clinical trials of potential disease-modifying therapies, including secondary prevention trials in asymptomatic individuals with biomarker evidence of preclinical Alzheimer's disease.
Seating guaranteed for the first 700 attendees only. Early arrival is encouraged.
Limit to two tickets per transaction. For group reservations, please call 949.824.9896.